Early OspA immune complex formation in animal models of Lyme disease

被引:10
作者
Schutzer, SE [1 ]
Luan, J [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Allergy & Iummunol, Newark, NJ 07103 USA
关键词
Lyme disease; Borrelia burgdorferi; antigen-antibody complexes; immune complexes; outer surface proteins; OspA; animal models;
D O I
10.1159/000070267
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Infection with Borrelia burgdorferi, the cause of Lyme disease, has been accompanied by a puzzling delayed antibody (Ab) response to B. burgdorferi antigens (Ags) including the abundant organism-specific outer surface proteins, such as the 31-kD OspA. In humans the response to nonspecific B. burgdorferi Ags has required 36 weeks. The response to OspA has rarely been detected by conventional methodology until months after infection, despite demonstrable T cell reactivity. Tick inoculation and low-dose intradermal inoculation animal models have been characterized by a comparable response to OspA. Using more sensitive biotin-avidin immunoblots and immune complex (IQ dissociation techniques, we demonstrated in humans that Ab to OspA is formed early but may remain at low levels or bound in IC. To see if this was a universal biologic response, animal models were analyzed by these methods. The results with mice, monkeys and rabbits show that IC Ab to OspA may be detected at the onset of infection. The data suggest that these animal models may be used to understand the immune response to B. burgdorferi and the pathogene sis of Lyme disease. With attention to unique B. burgdoferi Ags, these results are likely to have both clinical and diagnostic importance. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 18 条
[1]  
AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1
[2]  
BARTHOLD SW, 1993, AM J PATHOL, V143, P959
[3]   SPIROCHETES ISOLATED FROM THE BLOOD OF 2 PATIENTS WITH LYME-DISEASE [J].
BENACH, JL ;
BOSLER, EM ;
HANRAHAN, JP ;
COLEMAN, JL ;
HABICHT, GS ;
BAST, TF ;
CAMERON, DJ ;
ZIEGLER, JL ;
BARBOUR, AG ;
BURGDORFER, W ;
EDELMAN, R ;
KASLOW, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (13) :740-742
[4]   Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine [J].
deSilva, AM ;
Telford, SR ;
Brunet, LR ;
Barthold, SW ;
Fikrig, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :271-275
[5]  
Dunn J J, 1990, Protein Expr Purif, V1, P159, DOI 10.1016/1046-5928(90)90011-M
[6]  
FOLEY DM, 1995, J CLIN INVEST, V96, P865
[7]   FATE OF BORRELIA-BURGDORFERI DNA IN TISSUES OF INFECTED MICE AFTER ANTIBIOTIC-TREATMENT [J].
MALAWISTA, SE ;
BARTHOLD, SW ;
PERSING, DH .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1312-1316
[8]   Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: Exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease [J].
Montgomery, RR ;
Malawista, SE ;
Feen, KJM ;
Bockenstedt, LK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :261-269
[9]   EFFECTIVENESS OF ANTIMICROBIAL TREATMENT AGAINST BORRELIA-BURGDORFERI INFECTION IN MICE [J].
MOODY, KD ;
ADAMS, RL ;
BARTHOLD, SW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1567-1572
[10]   EARLY AND EARLY DISSEMINATED PHASES OF LYME-DISEASE IN THE RHESUS-MONKEY - A MODEL FOR INFECTION IN HUMANS [J].
PHILIPP, MT ;
AYDINTUG, MK ;
BOHM, RP ;
COGSWELL, FB ;
DENNIS, VA ;
LANNERS, HN ;
LOWRIE, RC ;
ROBERTS, ED ;
CONWAY, MD ;
KARACORLU, M ;
PEYMAN, GA ;
GUBLER, DJ ;
JOHNSON, BJB ;
PIESMAN, J ;
GU, Y .
INFECTION AND IMMUNITY, 1993, 61 (07) :3047-3059